On this page
COVID-19 vaccinations summary
Second Boosters Administered | 982,800 |
Total Doses Administered | 12,666,524 |
First Boosters Administered | 2,773,363 |
Percentage of 12+ who have completed primary course | 90.1% |
Percentage of eligible 50+ who have received second booster | 55.1% |
Percentage of eligible 18+ who have received first booster | 73.0% |
Metrics on this page can use one of two views of the data. An operational view or a person view. There are two main differences between the views which result in slightly different totals.
- Occasionally doses that are recorded as first doses in CIR are actually a person's second doses. This means they will appear as dose 1 in the operational view but will appear as completed primary course in the person view (this is a data entry issue only and does not impact the dose that the person received).
- Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view.
In short, the operational view shows how doses administered in New Zealand were recorded in CIR. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand.
Total Vaccinations
Vaccinations last week | Cumulative total | |
---|---|---|
First dose | 20 | 4,032,039 |
Second dose | 13 | 3,985,246 |
Third primary | 3 | 34,662 |
Booster 1 | 175 | 2,773,363 |
Booster 2 | 912 | 982,800 |
Booster 3 | 1,590 | 427,557 |
Paediatric First Dose | 25 | 271,694 |
Paediatric Second Dose | 30 | 158,276 |
Infant First Dose | 1 | 139 |
Infant Second Dose | 2 | 114 |
Infant Third Dose | 1 | 64 |
Total doses | 2,840 | 12,666,524 |
This table is an operational view.
Definitions
- Cumulative total: All vaccinations that have been administered and entered into the COVID-19 Immunisation Register and including Friday 29 September 2023.
- Vaccinations last week: Over the 7 days up to and including Friday 29 September 2023.
Booster breakdowns
Booster counts by ethnicity
Ethnicity | Booster 1 (16-17) | Booster 1 (18+) | Booster 2 (50+) |
---|---|---|---|
Māori | 1,053 | 254,639 | 61,668 |
Pacific Peoples | 706 | 154,952 | 27,162 |
Asian | 2,129 | 461,008 | 59,685 |
European/Other | 6,312 | 1,824,706 | 668,735 |
Unknown | 33 | 19,266 | 3,637 |
Total | 10,233 | 2,714,571 | 820,887 |
This table is a person view.
Booster 2 uptake by age group
Age Group | Eligible | Received | Uptake |
---|---|---|---|
12 to 17 | - | 148 | - |
18 to 34 | - | 34,622 | - |
35 to 49 | 634,981 | 109,689 | - |
50 to 64 | 729,923 | 280,806 | 38.5% |
65+ | 759,115 | 540,081 | 71.1% |
This table is a person view.
Vaccine uptake percentage by age band



Vaccine uptake percentage by District of residence 12+



* Note, this figure does not include 5-11 year olds
* Note, this figure does not include 5-11 year olds
Vaccinations by week



This chart shows the count of vaccinations administered in a given week from the COVID-19 Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.
Adverse events following immunisations (AEFI)
Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.
Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings.
View Medsafe data on COVID-19 vaccine adverse effects following immunisation